Orbimed Advisors LLC Calliditas Therapeutics Ab Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$23.34 - $36.65 $413,024 - $648,558
-17,696 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$21.61 - $25.69 $4.48 Million - $5.33 Million
-207,304 Reduced 92.14%
17,696 $425,000
Q2 2020

Aug 14, 2020
BUY
$19.17 - $23.2 $4.31 Million - $5.22 Million
225,000 New
225,000 $5.22 Million

Others Institutions Holding CALT

# of Institutions
2
Shares Held
1.84K
Call Options Held
0
Put Options Held
0
View Full List

About Calliditas Therapeutics AB

CALT Quotes by TradingView
  • Ticker CALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,624,800
  • Market Cap $1.06B
  • Description
  • Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...
More about CALT
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email